
Subha Madhavan
1.8K posts

Subha Madhavan
@subhamadhavan
Precision Medicine & Digital Health Leader, Data scientist, Great boss award, Force multiplier, Service to America award, Startup & NonProfit Board Governance








Important features when evaluating a potentially oncogenic fusion like LMNA-NTRK1: ✅stranding and directionality ✅ kinase domain preserved ✅ in-frame sciencedirect.com/science/articl…


Regenstrief CEO Dr. Peter Embí (@embimd) received recognition from @IBJNews for his work to address the pandemic in Indiana. Dr. Embí leads Indiana Pandemic Information Collaborative, which maintains dashboards tracking COVID-19 data.








Thought provoking graphic. I would say that despite initial (healthy) debate, most of us in the lung cancer space are recommending adjuvant osimertinib where available. #LCSM #ASCO21
























